{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:17:22Z","timestamp":1792700242233,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.intimp.2023.110207","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:33:47Z","timestamp":1682339627000},"page":"110207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8+ T cells showed synergistic effects on improved disease-free survival in treatment-na\u00efve CRC patients"],"prefix":"10.1016","volume":"119","author":[{"given":"Abdo","family":"Meyiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanbar","family":"Mahmoodi Chalbatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Al-Mterin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Malekraeisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Murshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Elkord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2023.110207_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0010","doi-asserted-by":"crossref","first-page":"1905935","DOI":"10.1080\/2162402X.2021.1905935","article-title":"License to kill: microsatellite instability and immune contexture","volume":"10","author":"Maby","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2023.110207_b0015","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2020.02039","article-title":"Crosstalk between the MSI status and tumor microenvironment in colorectal cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.23922\/jarc.2020-064","article-title":"Immunotherapy in colorectal cancer: current and future strategies","volume":"5","author":"Ooki","year":"2021","journal-title":"J Anus Rectum Colon"},{"issue":"3","key":"10.1016\/j.intimp.2023.110207_b0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.immuni.2016.02.025","article-title":"Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability","volume":"44","author":"Mlecnik","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0030","doi-asserted-by":"crossref","first-page":"13455","DOI":"10.1038\/s41598-019-49878-4","article-title":"Tumor infiltrating lymphocytes and macrophages improve survival in microsatellite unstable colorectal cancer","volume":"9","author":"Narayanan","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2023.110207_b0035","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.celrep.2016.10.009","article-title":"Genomic correlates of immune-cell infiltrates in colorectal carcinoma","volume":"17","author":"Giannakis","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0040","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41598-020-60255-4","article-title":"The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: a systematic review and meta-analysis","volume":"10","author":"Idos","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2023.110207_b0045","doi-asserted-by":"crossref","unstructured":"R.V. Granetto C, Fea E, et al., Correlation between the prognostic value of tumor-infiltrating lymphocytes (TILS) and sidedness in colorectal cancer (CC) patients (pts). Ann. Oncol. 28:iii94. (2017).","DOI":"10.1093\/annonc\/mdx261.267"},{"key":"10.1016\/j.intimp.2023.110207_b0050","doi-asserted-by":"crossref","unstructured":"P.J. Hurkat, S. Jain, R. Jain, A Immunology behind tumors: a mini review, Curr. Cancer Ther. Rev. 15 (2019) 174\u2013183.","DOI":"10.2174\/1573394714666180907143433"},{"issue":"4","key":"10.1016\/j.intimp.2023.110207_b0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2023.110207_b0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccell.2018.03.005","article-title":"Emerging concepts for immune checkpoint blockade-based combination therapies","volume":"33","author":"Zappasodi","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9010064","article-title":"Tumor-infiltrating lymphoid cells in colorectal cancer patients with varying disease stages and microsatellite instability-high\/stable tumors","volume":"9","author":"Toor","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2023.110207_b0070","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.3389\/fimmu.2019.02936","article-title":"Immune checkpoints in circulating and tumor-infiltrating CD4(+) T cell subsets in colorectal cancer patients","volume":"10","author":"Toor","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110207_b0075","article-title":"PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-na\u00efve CRC patients","author":"Al-Mterin","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.intimp.2023.110207_b0080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/mmr.2016.6065","article-title":"Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression","volume":"15","author":"Yu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2023.110207_b0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12032-014-0082-9","article-title":"The effect of immune microenvironment on the progression and prognosis of colorectal cancer","volume":"31","author":"Chen","year":"2014","journal-title":"Med. Oncol."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2023.110207_b0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.18632\/genesandcancer.180","article-title":"The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy","volume":"9","author":"Long","year":"2018","journal-title":"Genes Cancer"},{"issue":"13","key":"10.1016\/j.intimp.2023.110207_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133194","article-title":"Circulating and tumor-infiltrating immune checkpoint-expressing CD8(+) Treg\/T cell subsets and their associations with disease-free survival in colorectal cancer patients","volume":"14","author":"Alsalman","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2023.110207_b0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4048\/jbc.2018.21.e61","article-title":"T-cell immunoglobulin mucin 3 expression on tumor infiltrating lymphocytes as a positive prognosticator in triple-negative breast cancer","volume":"21","author":"Byun","year":"2018","journal-title":"J. Breast Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s40425-019-0814-7","article-title":"PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma","volume":"7","author":"Ma","year":"2019","journal-title":"J. ImmunoTherapy Cancer"},{"key":"10.1016\/j.intimp.2023.110207_b0110","doi-asserted-by":"crossref","first-page":"5440572","DOI":"10.1155\/2021\/5440572","article-title":"Prognostic role of TIGIT expression in patients with solid tumors: a meta-analysis","volume":"2021","author":"Xiao","year":"2021","journal-title":"J. Immunol. Res."},{"issue":"15_suppl","key":"10.1016\/j.intimp.2023.110207_b0115","doi-asserted-by":"crossref","first-page":"e15126","DOI":"10.1200\/JCO.2017.35.15_suppl.e15126","article-title":"Association of LAG-3 expression in tumor infiltrating immune cells with prognosis in patients with microsatellite instability high colon cancer","volume":"35","author":"Lee","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110207_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000957","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2023.110207_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108429","article-title":"Differential expression of TIM-3 in circulation and tumor microenvironment of colorectal cancer patients","volume":"215","author":"Khalaf","year":"2020","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110207_b0130","article-title":"Correlations between circulating and tumor-infiltrating CD4(+) Treg subsets with immune checkpoints in colorectal cancer patients with early and advanced stages","volume":"10","author":"Al-Mterin","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2023.110207_b0135","article-title":"Correlations between circulating and tumor-infiltrating CD4(+) T cell subsets with immune checkpoints in colorectal cancer","volume":"10","author":"Al-Mterin","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2023.110207_b0140","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1073\/pnas.1104303108","article-title":"Leukocyte composition of human breast cancer","volume":"109","author":"Ruffell","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.intimp.2023.110207_b0145","first-page":"e31144","article-title":"Association of tumor-infiltrating lymphocytes with survival in stages II and III colorectal cancer","volume":"14","author":"Vitorino","year":"2022","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.intimp.2023.110207_b0150","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1158\/1078-0432.CCR-14-1905","article-title":"Stromal CD8+ T-cell density\u2014a promising supplement to TNM staging in non-small cell lung cancer","volume":"21","author":"Donnem","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2023.110207_b0155","first-page":"5132","article-title":"Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2023.110207_b0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ebiom.2018.08.003","article-title":"ITGAE defines CD8+ tumor-infiltrating lymphocytes predicting a better prognostic survival in colorectal cancer","volume":"35","author":"Hu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2023.110207_b0165","doi-asserted-by":"crossref","unstructured":"E.A. Bindea, Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer, Immunity 39 (2013) 782\u201395.","DOI":"10.1016\/j.immuni.2013.10.003"},{"key":"10.1016\/j.intimp.2023.110207_b0170","doi-asserted-by":"crossref","unstructured":"E.A. Mei, Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis, Br. J. Cancer 110 (2014) 1595\u2013605.","DOI":"10.1038\/bjc.2014.46"},{"issue":"5","key":"10.1016\/j.intimp.2023.110207_b0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00262-008-0591-5","article-title":"Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells","volume":"58","author":"Liu","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.intimp.2023.110207_b0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00241263","article-title":"Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand","volume":"39","author":"Huard","year":"1994","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.intimp.2023.110207_b0185","doi-asserted-by":"crossref","first-page":"e0265908","DOI":"10.1371\/journal.pone.0265908","article-title":"Prognostic value of CD155\/TIGIT expression in patients with colorectal cancer","volume":"17","author":"Murakami","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaad.2019.03.012","article-title":"Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes","volume":"81","author":"Lee","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"16","key":"10.1016\/j.intimp.2023.110207_b0195","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2018-01-825265","article-title":"TIGIT immune checkpoint blockade restores CD8(+) T-cell immunity against multiple myeloma","volume":"132","author":"Guillerey","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2023.110207_b0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10549-013-2581-3","article-title":"The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer","volume":"139","author":"Muenst","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2023.110207_b0205","doi-asserted-by":"crossref","unstructured":"D. Ostroumov, S. Duong, J. Wingerath, N. Woller, M.P. Manns, K. Timrott, M. Kleine, W. Ramackers, S. Roessler, S. Nahnsen, S. Czemmel, O. Dittrich-Breiholz, T. Eggert, F. K\u00fchnel, T.C. Wirth, Transcriptome profiling identifies TIGIT as a marker of T-cell exhaustion in liver cancer, Hepatology (Baltimore, Md.) 73(4) (2021) 1399-1418.","DOI":"10.1002\/hep.31466"},{"key":"10.1016\/j.intimp.2023.110207_b0210","doi-asserted-by":"crossref","unstructured":"L. Xu, L. Liu, D. Yao, X. Zeng, Y. Zhang, J. Lai, J. Zhong, X. Zha, R. Zheng, Y. Lu, M. Li, Z. Jin, S. Hebbar Subramanyam, S. Chen, X. Huang, Y. Li, PD-1 and TIGIT are highly co-expressed on CD8(+) T cells in AML patient bone marrow, Front. Oncol. 11 (2021) 686156.","DOI":"10.3389\/fonc.2021.686156"},{"key":"10.1016\/j.intimp.2023.110207_b0215","doi-asserted-by":"crossref","unstructured":"M. Wang, J. Bu, M. Zhou, J. Sido, Y. Lin, G. Liu, Q. Lin, X. Xu, J.W. Leavenworth, E. Shen, CD8(+)T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients, Clin. Immunol. (Orlando, Fla.) 190 (2018) 64-73.","DOI":"10.1016\/j.clim.2017.08.021"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0220","doi-asserted-by":"crossref","first-page":"1954761","DOI":"10.1080\/2162402X.2021.1954761","article-title":"Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry","volume":"10","author":"Park","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0225","doi-asserted-by":"crossref","first-page":"20846","DOI":"10.1038\/s41598-020-77941-y","article-title":"Quantitative and functional characteristics of circulating and bone marrow PD-1- and TIM-3-positive T cells in treated multiple myeloma patients","volume":"10","author":"Batorov","year":"2020","journal-title":"Scient. Rep."},{"issue":"162","key":"10.1016\/j.intimp.2023.110207_b0230","first-page":"15","article-title":"Prospects of TIM-3 as a promising diagnostic and prognostic biomarker for cancer patients","volume":"31","author":"Chen","year":"2021","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110207_b0235","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.intimp.2015.09.017","article-title":"Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma","volume":"29","author":"Xu","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110207_b0240","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.21037\/tcr.2020.02.41","article-title":"Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.110207_b0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cjp2.193","article-title":"Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer","volume":"7","author":"Al-Badran","year":"2021","journal-title":"J. Pathol. Clin. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4149\/neo_2017_112","article-title":"Down-regulated expression of Tim-3 promotes invasion and metastasis of colorectal cancer cells","volume":"64","author":"Sun","year":"2017","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3892\/ijo.2020.5062","article-title":"High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer","volume":"57","author":"Kitsou","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110207_b0260","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/08820139.2020.1758130","article-title":"Upregulation of TIGIT and PD-1 in colorectal cancer with mismatch-repair deficiency","volume":"50","author":"Zhou","year":"2021","journal-title":"Immunol. Invest."},{"issue":"10","key":"10.1016\/j.intimp.2023.110207_b0265","doi-asserted-by":"crossref","first-page":"e002836","DOI":"10.1136\/jitc-2021-002836","article-title":"Increased coexpression of PD-L1 and TIM3\/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"J. ImmunoTherapy Cancer"},{"key":"10.1016\/j.intimp.2023.110207_b0270","doi-asserted-by":"crossref","unstructured":"D.S. Thommen, J. Schreiner, P. M\u00fcller, P. Herzig, A. Roller, A. Belousov, P. Umana, P. Pisa, C. Klein, M. Bacac, O.S. Fischer, W. Moersig, S. Savic Prince, V. Levitsky, V. Karanikas, D. Lardinois, A. Zippelius, Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors, Cancer Immunol. Res. 3(12) (2015) 1344-1355.","DOI":"10.1158\/2326-6066.CIR-15-0097"},{"issue":"15","key":"10.1016\/j.intimp.2023.110207_b0275","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-4175","article-title":"TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer","volume":"25","author":"Fucikova","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.110207_b0280","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1158\/0008-5472.CAN-16-0274","article-title":"Tim-3 expression on tumor-infiltrating PD-1(+)CD8(+) T cells correlates with poor clinical outcome in renal cell carcinoma","volume":"77","author":"Granier","year":"2017","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2023.110207_b0285","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.1402176","article-title":"The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects","volume":"194","author":"Tian","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110207_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.956090","article-title":"The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application","volume":"13","author":"Huo","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0295","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12967-020-02469-8","article-title":"Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8(+)T cells in hepatocellular carcinoma using multiplex quantitative analysis","volume":"18","author":"Guo","year":"2020","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.110207_b0300","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.33358","article-title":"Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients","volume":"148","author":"Lv","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"17","key":"10.1016\/j.intimp.2023.110207_b0305","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1073\/pnas.1003345107","article-title":"Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer","volume":"107","author":"Matsuzaki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.intimp.2023.110207_b0310","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.110207_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2021.05.001","article-title":"Advances and new frontiers for immunotherapy in colorectal cancer: setting the stage for neoadjuvant success?","volume":"22","author":"Sumransub","year":"2021","journal-title":"Mol. Ther. Oncolyt."},{"issue":"1","key":"10.1016\/j.intimp.2023.110207_b0320","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","article-title":"The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints","volume":"5","author":"Llosa","year":"2015","journal-title":"Cancer Discov."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923005283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923005283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:33:28Z","timestamp":1785771208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923005283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":64,"alternative-id":["S1567576923005283"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110207","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8+ T cells showed synergistic effects on improved disease-free survival in treatment-na\u00efve CRC patients","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110207"}}